51 – 60 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Monoclonal anti-mouse laminin antibodies: AL-1 reacts with laminin alpha1 chain, AL-2 with laminin beta1 chain, and AL-4 with the coiled-coil domain of laminin beta1 chain.
- Contribution to journal › Article
-
Mark
Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan.
- Contribution to journal › Article
-
Mark
Extraocular muscle is spared upon complete laminin alpha2 chain deficiency: Comparative expression of laminin and integrin isoforms.
- Contribution to journal › Article
-
Mark
Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis.
- Contribution to journal › Article
-
Mark
Laminin {alpha}1 chain improves laminin {alpha}2 chain deficient peripheral neuropathy.
- Contribution to journal › Article
- 2005
-
Mark
Laminin {alpha}1 Chain Corrects Male Infertility Caused by Absence of Laminin {alpha}2 Chain.
- Contribution to journal › Article
-
Mark
Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation
- Contribution to journal › Article
- 2004
-
Mark
Laminin {alpha}1 chain reduces muscular dystrophy in laminin {alpha}2 chain deficient mice.
- Contribution to journal › Article
- 2003
-
Mark
Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy
- Contribution to journal › Article
- 2002
-
Mark
Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models
- Contribution to journal › Article